Vimarsana
Biggest News Aggregation in the World

Page 13 - Simulations Plus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Simulations Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Simulations Plus Today - Breaking & Trending Today

Simulations Plus Hosts First-of-its-Kind Virtual Summer Camp for Students and Professors - Vimarsana News

Simulations Plus Hosts First-of-its-Kind Virtual Summer Camp for Students and Professors

Immersive activities helped attendees globally learn and apply best practices for PBPK modeling ...

Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS) - Vimarsana News

Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS)

Dr. Lukacova’s outstanding contributions to pharmaceutical research and innovation to be recognized with seven others at AAPS PharmSci 360 ...

Financial Analysis: ECARX (NASDAQ:ECX) & Simulations Plus (NASDAQ:SLP) - Vimarsana News

Financial Analysis: ECARX (NASDAQ:ECX) & Simulations Plus (NASDAQ:SLP)

ECARX (NASDAQ:ECX – Get Free Report) and Simulations Plus (NASDAQ:SLP – Get Free Report) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk. Analyst Ratings This is a summary of […]

Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment - Vimarsana News

Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment

Elevated ALT levels during clinical trials led researchers to use quantitative systems toxicology software to better understand potential underlying mechanisms ... -Today at 08:34 am- MarketScreener

The Biosimulation Market size to grow at a CAGR of 15.06% from 2022 to 2027 | An increase in research funding and grants to boost market growth - Vimarsana News

The Biosimulation Market size to grow at a CAGR of 15.06% from 2022 to 2027 | An increase in research funding and grants to boost market growth

/PRNewswire/ -- The biosimulation market is to grow by USD 3,163.61 million from 2022 to 2027 and register a CAGR of 15.06%, according to Technavio's latest...